lysylglutamic-acid has been researched along with Urinary-Bladder-Neoplasms* in 2 studies
2 other study(ies) available for lysylglutamic-acid and Urinary-Bladder-Neoplasms
| Article | Year |
|---|---|
Inhibitory effect of peptide vilon on the development of induced rat urinary bladder tumors in rats.
The effect of peptide vilon (Lys-Glu) on urinary bladder carcinogenesis in rats was studied. Urinary bladder tumors were induced with a selective carcinogen N-butyl-N-(4-hydroxybutyl)nitrosamine. The tumors developed in 56% vilon-treated animals and in 75.5% controls. Vilon 2-fold decreased the incidence of preneoplastic and early neoplastic changes in urinary bladder mucosa and significantly inhibited carcinogenesis. Topics: Adjuvants, Immunologic; Animals; Butylhydroxybutylnitrosamine; Carcinogens; Dipeptides; Male; Rats; Urinary Bladder Neoplasms | 2001 |
[Effect of vilon and epithalone on induction and growth of induced bladder neoplasms in rats].
Experimental data on the effect of peptides--Vilon (Lys-Glu) and Epitalon (Ala-Glu-Asp-Gly)--on induction of urinary bladder tumors in rats are presented. Treatment with Vilon was followed by a significant fall in tumor incidence in 56% of experimental animals, as compared with 75.5% in control, as well as inhibition of early-onset neoplastic changes in the bladder mucosa. No inhibitory effect of Epitalon was recorded. Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Dipeptides; Male; Oligopeptides; Rats; Urinary Bladder Neoplasms | 2001 |